Scientists with the Institute of Biomedical Sciences and School of Life Sciences at East China Normal University wrote “Smartphone-controlled optogenetically engineered cells enable semiautomatic glucose homeostasis in diabetic mice” in the April 2017 issue of Science Translational Medicine. The researchers used SpectrumLabs.com’s hollow fiber membranes as implants in mice to monitor diabetes through mobile devices.

Mobile health is increasingly patient-centric, as the authors of the paper describe. The scientists applied the use of implant technology and the ever-expanding smartphone capabilities to monitor diabetes in mice. Personalized health tracking is not new to the field, however, the researchers believe the technology they developed closes the limitations previous iterations display.

Abstract: With the increasingly dominant role of smartphones in our lives, mobile health care systems integrating advanced point-of-care technologies to manage chronic diseases are gaining attention. Using a multidisciplinary design principle coupling electrical engineering, software development, and synthetic biology, we have engineered a technological infrastructure enabling the smartphone-assisted semiautomatic treatment of diabetes in mice. Click here to read the article.

 

Hollow Fiber (HF) Microfiltration is ideal for cold sterilization, sample clarification or point-of-use filtration. Spectrum’s Hollow Fiber Microfilters are ingeniously designed with looped DynaFibre® membrane (0.2 µm mixed cellulose ester hollow fiber) in a small filter device to maximize surface area (SA) and flow rate while minimizing membrane plugging and protein-binding.

doi: 10.1126/scitranslmed.aal2298